Shopping Cart 0
Cart Subtotal
USD 0

Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM Imaging's agents include EMI-137 for CRC Lesion, EMI-200 for inflammation, EMI-300 and 350 for lung infection, EMI-400 for lung fibrosis, EMI-500 for breast cancer, and EMI-600 for single pulmonary nodules. The company develops optical imaging platform which shows the increased fluorescent signal from the optical agents on target engagement in a diseased patient. EM Imaging is headquartered in Edinburgh, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Edinburgh Molecular Imaging Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Edinburgh Molecular Imaging Ltd Company Overview

Edinburgh Molecular Imaging Ltd Company Snapshot

Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview

Edinburgh Molecular Imaging Ltd-Pipeline Analysis Overview

Edinburgh Molecular Imaging Ltd-Key Facts

Edinburgh Molecular Imaging Ltd-Major Products and Services

Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status

Edinburgh Molecular Imaging Ltd Pipeline Products Overview

EMI-137

EMI-137 Product Overview

EMI-137 Clinical Trial

EMI-200

EMI-200 Product Overview

EMI-300/350

EMI-300/350 Product Overview

EMI-400

EMI-400 Product Overview

EMI-500

EMI-500 Product Overview

EMI-600

EMI-600 Product Overview

Edinburgh Molecular Imaging Ltd-Key Competitors

Edinburgh Molecular Imaging Ltd-Key Employees

Edinburgh Molecular Imaging Ltd-Locations And Subsidiaries

Head Office

Recent Developments

Edinburgh Molecular Imaging Ltd, Recent Developments

Nov 08, 2018: Edinburgh Molecular Imaging appoints Bernhard Sixt as new Chief Executive Officer

Oct 29, 2018: Edinburgh Molecular Imaging appoints new chairman

Sep 20, 2017: Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Mar 09, 2016: Edinburgh Molecular Imaging Awarded Innovate UK Grant To Qualify The Role Of EMI-137 In Colorectal Cancer Lesion Detection

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type

Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview

Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type

Edinburgh Molecular Imaging Ltd Pipeline Products by Indication

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status

Edinburgh Molecular Imaging Ltd, Key Facts

Edinburgh Molecular Imaging Ltd, Major Products and Services

Edinburgh Molecular Imaging Ltd Number of Pipeline Products by Development Stage

Edinburgh Molecular Imaging Ltd Pipeline Products Summary by Development Stage

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials Summary

EMI-137-Product Status

EMI-137-Product Description

EMI-137-Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Imaging: A Multicentre Feasibility and

EMI-137-Exploratory Study to Optically Visualise Activated Neutrophils and the Proto-oncogene, c-MET, in Lung Cancer Using DUAL Colour Fibre-based Endomicroscopy

EMI-137-Intraoperative Imaging of Colon Cancer Using a Fluorescent Peptide (EMI-137) Against the c-Met Receptor

EMI-137-Molecular Fluorescence Endoscopy for the Detection of (Pre) Malignant Lesions in Barrett's Esophagus Using a Fluorescent Tracer 'EMI-137' Targeting c-Met: A Single-center Feasibility and Safety Study

EMI-200-Product Status

EMI-200-Product Description

EMI-300/350-Product Status

EMI-300/350-Product Description

EMI-400-Product Status

EMI-400-Product Description

EMI-500-Product Status

EMI-500-Product Description

EMI-600-Product Status

EMI-600-Product Description

Edinburgh Molecular Imaging Ltd, Key Employees

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Edinburgh Molecular Imaging Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Alliance Medical Ltd

Imanova Ltd

Imaging Equipment Ltd

Company Profile

Company Profile Title

Summary

Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM Imaging's agents include EMI-137 for CRC Lesion, EMI-200 for inflammation, EMI-300 and 350 for lung infection, EMI-400 for lung fibrosis, EMI-500 for breast cancer, and EMI-600 for single pulmonary nodules. The company develops optical imaging platform which shows the increased fluorescent signal from the optical agents on target engagement in a diseased patient. EM Imaging is headquartered in Edinburgh, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Edinburgh Molecular Imaging Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Edinburgh Molecular Imaging Ltd Company Overview

Edinburgh Molecular Imaging Ltd Company Snapshot

Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview

Edinburgh Molecular Imaging Ltd-Pipeline Analysis Overview

Edinburgh Molecular Imaging Ltd-Key Facts

Edinburgh Molecular Imaging Ltd-Major Products and Services

Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status

Edinburgh Molecular Imaging Ltd Pipeline Products Overview

EMI-137

EMI-137 Product Overview

EMI-137 Clinical Trial

EMI-200

EMI-200 Product Overview

EMI-300/350

EMI-300/350 Product Overview

EMI-400

EMI-400 Product Overview

EMI-500

EMI-500 Product Overview

EMI-600

EMI-600 Product Overview

Edinburgh Molecular Imaging Ltd-Key Competitors

Edinburgh Molecular Imaging Ltd-Key Employees

Edinburgh Molecular Imaging Ltd-Locations And Subsidiaries

Head Office

Recent Developments

Edinburgh Molecular Imaging Ltd, Recent Developments

Nov 08, 2018: Edinburgh Molecular Imaging appoints Bernhard Sixt as new Chief Executive Officer

Oct 29, 2018: Edinburgh Molecular Imaging appoints new chairman

Sep 20, 2017: Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Mar 09, 2016: Edinburgh Molecular Imaging Awarded Innovate UK Grant To Qualify The Role Of EMI-137 In Colorectal Cancer Lesion Detection

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type

Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview

Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type

Edinburgh Molecular Imaging Ltd Pipeline Products by Indication

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status

Edinburgh Molecular Imaging Ltd, Key Facts

Edinburgh Molecular Imaging Ltd, Major Products and Services

Edinburgh Molecular Imaging Ltd Number of Pipeline Products by Development Stage

Edinburgh Molecular Imaging Ltd Pipeline Products Summary by Development Stage

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status

Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials Summary

EMI-137-Product Status

EMI-137-Product Description

EMI-137-Detection of Thyroid Cancer and Central Lymph Node Metastases Using EMI-137 Enhanced Molecular Fluorescent Guided Imaging: A Multicentre Feasibility and

EMI-137-Exploratory Study to Optically Visualise Activated Neutrophils and the Proto-oncogene, c-MET, in Lung Cancer Using DUAL Colour Fibre-based Endomicroscopy

EMI-137-Intraoperative Imaging of Colon Cancer Using a Fluorescent Peptide (EMI-137) Against the c-Met Receptor

EMI-137-Molecular Fluorescence Endoscopy for the Detection of (Pre) Malignant Lesions in Barrett's Esophagus Using a Fluorescent Tracer 'EMI-137' Targeting c-Met: A Single-center Feasibility and Safety Study

EMI-200-Product Status

EMI-200-Product Description

EMI-300/350-Product Status

EMI-300/350-Product Description

EMI-400-Product Status

EMI-400-Product Description

EMI-500-Product Status

EMI-500-Product Description

EMI-600-Product Status

EMI-600-Product Description

Edinburgh Molecular Imaging Ltd, Key Employees

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Edinburgh Molecular Imaging Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Alliance Medical Ltd

Imanova Ltd

Imaging Equipment Ltd